XEWE:XETRA:XETRA-Xtrackers S&P 500 Equal Weight ESG UCITS ETF 2C- EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 10.108

Change

+0.32 (+3.29)%

Market Cap

USD 2.73B

Volume

3.33K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.75%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.95 (+1.05%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.38 (+1.75%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.18 (+1.45%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.10 (+1.97%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.34 (+1.61%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.08 (+0.71%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.62 (+1.12%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.04 (+0.43%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.48 (+0.40%)

USD 12.26B

ETFs Containing XEWE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.84% 46% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.84% 48% F 46% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.73B 92% A 73% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike